arrow_back Trending Legislation
Share share

Medicine Stockpile: Ensuring Access to Generic Drugs for Americans

This new law aims to create stockpiles of essential generic drugs to prevent shortages. This will ensure that citizens have access to necessary medications, enhancing health security and reducing the risk of treatment interruptions.
Key points
Establishing strategic stockpiles of generic drugs at risk of shortage to ensure at least 6 months of supply.
Selecting up to 50 key generic drugs for the stockpile program, with a publicly available list.
Pharmaceutical companies will manage these stockpiles, selling older batches and replacing them to prevent expiration.
The government will pay companies for maintaining these stockpiles, and their operations will be regularly audited.
The goal is to prevent situations where citizens cannot obtain needed medications due to market shortages.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Essential Medicines Strategic Stockpile Act of 2021
Print number: HR 2870
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
Process start date: 2021-04-28
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Medicine Stockpile: Ensuring Access to Generic Drugs for Americans

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 2870.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-04-28.

What are the main provisions?

Key points include:

  • Establishing strategic stockpiles of generic drugs at risk of shortage to ensure at least 6 months of supply.
  • Selecting up to 50 key generic drugs for the stockpile program, with a publicly available list.
  • Pharmaceutical companies will manage these stockpiles, selling older batches and replacing them to prevent expiration.
  • The government will pay companies for maintaining these stockpiles, and their operations will be regularly audited.
  • The goal is to prevent situations where citizens cannot obtain needed medications due to market shortages.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Carter, Earl L. "Buddy" [R-GA-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

Analysis and Potential Impact of HR 2870

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health